Atezolizumab with bevacizumab: a powerful immunotherapy approach for first-line therapy of liver cancer.
Tebentafusp is a pharmacological breakthrough in the fight against a deadly disease.
Atara Biotherapeutics and its awesome T-cell therapy against Epstein–Barr virus can really cure progressive forms of multiple sclerosis.
Acne vulgaris treatment will reach a new level of quality.
UK-based GammaDelta Therapeutics has developed a pipeline of novel allogeneic cell therapies.
The autoimmune disease will be defeated by restoring immune tolerance.
Nivolumab or pembrolizumab should be added to standard chemotherapy to prolong the life of patients with gastric, esophageal, and gastroesophageal junction cancers.